| Product Code: ETC099500 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The United States gastrointestinal devices market is a rapidly growing sector fueled by technological advancements and an increasing prevalence of gastrointestinal disorders. The market includes a wide range of devices such as endoscopes, stents, dilation devices, and enteral feeding tubes. Factors driving market growth include a rising aging population, higher incidence of gastrointestinal diseases like colorectal cancer and inflammatory bowel disease, and a surge in minimally invasive procedures. Key players in the US gastrointestinal devices market include Boston Scientific Corporation, Medtronic plc, and Olympus Corporation. The market is highly competitive, with companies focusing on innovation, strategic collaborations, and product launches to gain a competitive edge. Regulatory approvals, reimbursement issues, and the need for skilled healthcare professionals are some challenges faced by market players in this dynamic and evolving sector.
The United States gastrointestinal devices market is experiencing several key trends. Firstly, there is a growing demand for minimally invasive procedures, leading to the development and adoption of advanced endoscopic devices such as capsule endoscopes and endoscopic ultrasound systems. Secondly, there is an increasing focus on the integration of digital technologies in gastrointestinal devices, including smart pills and remote monitoring systems, to enhance diagnosis and treatment outcomes. Additionally, there is a rising prevalence of gastrointestinal disorders such as inflammatory bowel disease and colorectal cancer, driving the demand for innovative devices for early detection and therapy. Moreover, the shift towards value-based care and cost-effectiveness is prompting manufacturers to develop more efficient and affordable devices. Overall, these trends are shaping a dynamic and competitive landscape in the US gastrointestinal devices market.
In the US Gastrointestinal devices market, key challenges include stringent regulatory approval processes, high costs associated with research and development, and increasing competition from both established and emerging companies. The regulatory landscape in the US is complex, requiring companies to meet stringent requirements for safety and effectiveness before their products can be commercialized. Additionally, the high costs of developing new gastrointestinal devices and conducting clinical trials can be prohibitive for smaller companies, limiting innovation in the market. Furthermore, the growing number of competitors in the market intensifies the need for differentiation and innovation to capture market share. Overall, navigating regulatory hurdles, managing costs, and staying ahead of the competition are significant challenges in the US gastrointestinal devices market.
The US Gastrointestinal devices market offers promising investment opportunities due to factors such as the increasing prevalence of gastrointestinal disorders, advancements in technology leading to the development of innovative devices, and a growing aging population in need of such devices. Key areas for investment include endoscopic devices for diagnostics and therapeutics, capsule endoscopy devices, stents, and enteral feeding devices. With a rising demand for minimally invasive procedures and a focus on improving patient outcomes, companies developing cutting-edge gastrointestinal devices stand to benefit from a growing market. Additionally, partnerships with healthcare providers and strategic acquisitions can further drive growth and market penetration in this sector. Overall, the US Gastrointestinal devices market presents a lucrative opportunity for investors looking to capitalize on the evolving healthcare landscape and technological advancements in this field.
Government policies related to the US Gastrointestinal devices market primarily focus on ensuring the safety, efficacy, and quality of medical devices. The Food and Drug Administration (FDA) regulates gastrointestinal devices through the premarket approval (PMA) process, which requires manufacturers to demonstrate the device`s safety and effectiveness before it can be marketed. Additionally, the FDA monitors post-market surveillance to identify and address any safety concerns that may arise. Reimbursement policies from government payers such as Medicare also play a crucial role in shaping the market dynamics by determining the level of coverage and reimbursement rates for gastrointestinal devices. Overall, government policies in the US gastrointestinal devices market aim to protect patient safety, promote innovation, and ensure access to high-quality medical devices.
The United States gastrointestinal devices market is expected to experience steady growth in the coming years due to increasing prevalence of gastrointestinal disorders such as Crohn`s disease, ulcerative colitis, and irritable bowel syndrome. Technological advancements in endoscopic procedures, minimally invasive surgeries, and innovative devices for diagnosing and treating gastrointestinal conditions are likely to drive market expansion. Additionally, the aging population in the US, coupled with rising awareness about digestive health and the importance of early diagnosis, will contribute to market growth. Key players in the industry are focusing on developing advanced devices with improved efficacy and safety profiles to meet the evolving needs of healthcare providers and patients. Overall, the US gastrointestinal devices market is poised for sustained growth and innovation in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Gastrointestinal devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Gastrointestinal devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Gastrointestinal devices Market - Industry Life Cycle |
3.4 United States (US) Gastrointestinal devices Market - Porter's Five Forces |
3.5 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By Sales channel, 2021 & 2031F |
3.7 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 United States (US) Gastrointestinal devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal disorders in the US population |
4.2.2 Advancements in technology leading to the development of innovative gastrointestinal devices |
4.2.3 Rising adoption of minimally invasive procedures for gastrointestinal treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of gastrointestinal devices |
4.3.2 High cost associated with gastrointestinal devices impacting affordability |
4.3.3 Limited reimbursement policies for certain gastrointestinal procedures |
5 United States (US) Gastrointestinal devices Market Trends |
6 United States (US) Gastrointestinal devices Market, By Types |
6.1 United States (US) Gastrointestinal devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Type, 2018 - 2027F |
6.1.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By GI Videoscopes, 2018 - 2027F |
6.1.4 United States (US) Gastrointestinal devices Market Revenues & Volume, By Biopsy Devices, 2018 - 2027F |
6.1.5 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), 2018 - 2027F |
6.1.6 United States (US) Gastrointestinal devices Market Revenues & Volume, By Capsule Endoscopy, 2018 - 2027F |
6.1.7 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Ultrasound, 2018 - 2027F |
6.1.8 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Mucosal Resection (EMR), 2018 - 2027F |
6.1.9 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2018 - 2027F |
6.1.10 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 United States (US) Gastrointestinal devices Market, By Sales channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Online Retailing, 2018 - 2027F |
6.2.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By Medical Stores & Brand Outlet, 2018 - 2027F |
6.3 United States (US) Gastrointestinal devices Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By Clinics & Dialysis Centers, 2018 - 2027F |
6.3.4 United States (US) Gastrointestinal devices Market Revenues & Volume, By Ambulatory Surgical Center, 2018 - 2027F |
6.3.5 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2018 - 2027F |
7 United States (US) Gastrointestinal devices Market Import-Export Trade Statistics |
7.1 United States (US) Gastrointestinal devices Market Export to Major Countries |
7.2 United States (US) Gastrointestinal devices Market Imports from Major Countries |
8 United States (US) Gastrointestinal devices Market Key Performance Indicators |
8.1 Number of FDA approvals for new gastrointestinal devices |
8.2 Rate of adoption of minimally invasive gastrointestinal procedures |
8.3 Investment in research and development for gastrointestinal devices |
8.4 Patient satisfaction and outcomes post gastrointestinal device procedures |
8.5 Utilization rate of gastrointestinal devices in healthcare facilities |
9 United States (US) Gastrointestinal devices Market - Opportunity Assessment |
9.1 United States (US) Gastrointestinal devices Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Gastrointestinal devices Market Opportunity Assessment, By Sales channel, 2021 & 2031F |
9.3 United States (US) Gastrointestinal devices Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 United States (US) Gastrointestinal devices Market - Competitive Landscape |
10.1 United States (US) Gastrointestinal devices Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Gastrointestinal devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |